SIRINGO, MARCO
SIRINGO, MARCO
DIPARTIMENTO DI MEDICINA MOLECOLARE
ADJUVANT TREATMENT IN ELDERLY CANCER PATIENTS: A MULTICENTER REAL-LIFE EXPERIENCE
2017 Siringo, Marco
Adjuvant treatment in elderly cancer patients: a multicenter real-life experience
2017 Bassanelli, M.; Ceribelli, A.; Giannarelli, D.; Giacinti, S.; Viterbo, A.; Siringo, M.; Poti, G.; Roberto, M.; Macrini, S.; Falcone, R.; Giuli, A.; Di Pietro, F. R.; Aschelter, A. M.; Marchetti, P.
Advanced non-small-cell lung cancer: how to manage EGFR and HER2 exon 20 insertion mutation-positive disease
2022 Metro, Giulio; De Giglio, Andrea; Ricciuti, Biagio; Siringo, Marco; Marinelli, Daniele; Gelibter, Alain; Pecci, Federica; Berardi, Rossana; Cantini, Luca; Di Federico, Alessandro; Andrini, Elisa; Mosca, Mirta; Lamberti, Giuseppe; Brambilla, Marta; Mountzios, Giannis
Anti-PD1 therapies induce an early expansion of Ki67+CD8+ T cells in metastatic non-oncogene addicted NSCLC patients
2024 Gelibter, Alain; Tuosto, Lucrezia; Asquino, Angela; Siringo, Marco; Sabatini, Arianna; Zizzari, ILARIA GRAZIA; Pace, Angelica; Scirocchi, Fabio; Valentino, Flavio; Bianchini, Serena; Caponnetto, Salvatore; Paoli, Donatella; Bellati, Filippo; Santini, Daniele; Nuti, Marianna; Rughetti, Aurelia; Napoletano, Chiara
Blood Extracellular Vesicles beyond Circulating Tumour Cells: A Valuable Risk Stratification Biomarker in High-Risk Non-Muscle-Invasive Bladder Cancer Patients
2024 Magri, Valentina; Marino, Luca; DEL GIUDICE, Francesco; DE MEO, Michela; Siringo, Marco; DE BERARDINIS, Ettore; Gandini, Orietta; Santini, Daniele; Nicolazzo, Chiara; Gazzaniga, Paola
CD137+ and regulatory T cells as independent prognostic factors of survival in advanced non-oncogene addicted NSCLC patients treated with immunotherapy as first-line
2024 Gelibter, Alain; Asquino, Angela; Strigari, Lidia; Zizzari, Ilaria; Tuosto, Lucrezia; Scirocchi, Fabio; Pace, Angelica; Siringo, Marco; Tramontano, Elisa; Bianchini, Serena; Bellati, Filippo; Botticelli, Andrea; Paoli, Donatella; Santini, Daniele; Nuti, Marianna; Rughetti, Aurelia; Napoletano, Chiara
Circulating Cancer-Associated Macrophage-like Cells as a Blood-Based Biomarker of Response to Immune Checkpoint Inhibitors
2024 Magri, Valentina; DE RENZI, Gianluigi; Marino, Luca; DE MEO, Michela; Siringo, Marco; Gelibter, Alain; Gareri, Roberta; Cataldi, Chiara; Giannini, Giuseppe; Santini, Daniele; Nicolazzo, Chiara; Gazzaniga, Paola
Circulating CD137+ T cell subsets and MDCSs as immune biomarkers for response to anti-PD1 immunotherapy in NSCLC patients
2023 Asquino, Angela; Tuosto, Lucrezia; Scirocchi, Fabio; Pace, Angelica; Zizzari, ILARIA GRAZIA; Siringo, Marco; Tramontano, Elisa; Gelibter, Alain; Cortesi, Enrico; Nuti, Marianna; Rughetti, Aurelia; Napoletano, Chiara
Circulating CD137+T cells as an immune biomarker for response to anti-PD1 immunotherapy in NSCLC patients
2023 Asquino, Angela; Scirocchi, Fabio; Pace, Angelica; Zizzari, ILARIA GRAZIA; Siringo, Marco; Tramontano, Elisa; Cortesi, Enrico; Gelibter, Alain; Nuti, Marianna; Rughetti, Aurelia; Napoletano, Chiara
Clinical utility of combined plasma and tissue NGS in patients with advanced, treatment-naïve, Non-small Cell Lung Cancer
2023 Bote de Cabo, H.; Siringo, M.; García-Lorenzo, E.; Castelo, A.; Conde, E.; Hernández, S.; López-Ríos Moreno, F.; Herrera, M.; Baena, J.; Ruano-Domínguez, Y.; Enguita, A. B.; Pérez, U.; Paz-Ares, L.; Zugazagoitia, J.
Clinical Utility of Combined Plasma and Tissue NGS in Patients With Newly Diagnosed Advanced Non-Small Cell Lung Cancer
2023 Bote De Cabo, H.; Siringo, M.; García-Lorenzo, E.; Castelo, A.; Conde, E.; Hernández, S.; López-Ríos Moreno, F.; Paz-Ares, L.; Zugazagoitia, J.
Clinical Utility of Combined Tissue and Plasma Next-Generation Sequencing in Patients with Advanced, Treatment-Naïve, Non-Small-Cell Lung Cancer
2024 Cabo, Helena Bote-de; Siringo, Marco; Conde, Esther; Hernández, Susana; López-Ríos, Fernando; Castelo-Loureiro, Alicia; García-Lorenzo, Esther; Baena, Javier; Herrera, Mercedes; Enguita, Ana Belén; Ruano, Yolanda; Zugazagoitia, Jon; Paz-Ares, Luis
Co-Occurrence of ALK rearrangement and KRAS G12C mutation in NSCLC. Report of two cases
2024 Siringo, M; Larocca, F; Spagnuolo, A; Gentile, G; Anile, M; Diso, D; Santini, D; Gelibter, A
Comparison between liquid biopsy and tissue NGS in two cohorts of advanced NSCLC
2023 Bote, Helena; Siringo, Marco; García-Lorenzo, Esther; Castelo, Alicia; Conde, Esther; Hernández, Susana; Herrera, Mercedes; Ruano-Domínguez, Yolanda; Baena, Javier; Enguita, Ana Belén; Lopez-Rios Moreno, Fernando; Zugazagoitia, Jon; Paz-Ares, Luis G.
Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy
2021 Cortellini, A.; Di Maio, M.; Nigro, O.; Leonetti, A.; Cortinovis, D. L.; Aerts, J. G. J. V.; Guaitoli, G.; Barbieri, F.; Giusti, R.; Ferrara, M. G.; Bria, E.; D'Argento, E.; Grossi, F.; Rijavec, E.; Guida, A.; Berardi, R.; Torniai, M.; Sforza, V.; Genova, C.; Mazzoni, F.; Garassino, M. C.; De Toma, A.; Signorelli, D.; Gelibter, A.; Siringo, M.; Marchetti, P.; Macerelli, M.; Rastelli, F.; Chiari, R.; Rocco, D.; Della Gravara, L.; Inno, A.; Michele, D. T.; Grassadonia, A.; Di Marino, P.; Mansueto, G.; Zoratto, F.; Filetti, M.; Santini, D.; Citarella, F.; Russano, M.; Cantini, L.; Tuzi, A.; Bordi, P.; Minuti, G.; Landi, L.; Ricciardi, S.; Migliorino, M. R.; Passiglia, F.; Bironzo, P.; Metro, G.; Adamo, V.; Russo, A.; Spinelli, G. P.; Banna, G. L.; Friedlaender, A.; Addeo, A.; Cannita, K.; Ficorella, C.; Porzio, G.; Pinato, D. J.
EP08.02-046 Activity of OsimeRTInib in NSCLC with Uncommon EGFR Mutations: Retrospective Observational Multicenter Study (ARTICUNO)
2022 Pizzutilo, E. G.; Agostara, A. G.; Oresti, S.; Signorelli, D.; Giannetta, L. G.; Stabile, S.; Lauricella, C.; Amatu, A.; Brambilla, M.; Lo Russo, G.; Proto, C.; Mazzeo, L.; Beninato, T.; Siringo, M.; Giusti, R.; Filetti, M.; Genova, C.; Barletta, G.; Russano, M.; Di Fazio, G. R.; Tosoni, E.; Metro, G.; Pilotto, S.; Carta, A.; Mazzoni, F.; Roca, E.; Gelibter, A. J.; Gori, S.; Berardi, R.; Cerea, G.; Sartore-Bianchi, A.; Siena, S.
Evaluation of efficacy of ALK inhibitors according to body mass index in ALK rearranged NSCLC patients—A retrospective observational study
2023 Siringo, Marco; Gentile, Gabriella; Caponnetto, Salvatore; Sperduti, Isabella; Santini, Daniele; Cortesi, Enrico; Gelibter, ALAIN JONATHAN
Future Perspectives in the Second Line Therapeutic Setting for Non-Oncogene Addicted Non-Small-Cell Lung Cancer
2023 Siringo, Marco; Baena, Javier; Bote de Cabo, Helena; Torres-Jiménez, Javier; Zurera, María; Zugazagoitia, Jon; Paz-Ares, Luis
Immunological network signature of naïve non-oncogene-addicted non-small cell lung cancer patients treated with anti-PD1 therapy. A pilot study
2025 Sibilio, Pasquale; Zizzari, ILARIA GRAZIA; Gelibter, Alain; Siringo, Marco; Tuosto, Lucrezia; Pace, Angelica; Asquino, Angela; Valentino, Flavio; Sabatini, Arianna; Petti, Manuela; Bellati, Filippo; Santini, Daniele; Nuti, Marianna; Farina, Lorenzo; Rughetti, Aurelia; Napoletano, Chiara
Non-small-cell lung cancer: how to manage ALK-, ROS1- and NTRK-rearranged disease
2022 Marinelli, Daniele; Siringo, Marco; Metro, Giulio; Ricciuti, Biagio; Gelibter, Alain J
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| ADJUVANT TREATMENT IN ELDERLY CANCER PATIENTS: A MULTICENTER REAL-LIFE EXPERIENCE | 2017 | Siringo, Marco | |
| Adjuvant treatment in elderly cancer patients: a multicenter real-life experience | 2017 | Bassanelli, M.; Ceribelli, A.; Giannarelli, D.; Giacinti, S.; Viterbo, A.; Siringo, M.; Poti, G.; Roberto, M.; Macrini, S.; Falcone, R.; Giuli, A.; Di Pietro, F. R.; Aschelter, A. M.; Marchetti, P. | |
| Advanced non-small-cell lung cancer: how to manage EGFR and HER2 exon 20 insertion mutation-positive disease | 2022 | Metro, Giulio; De Giglio, Andrea; Ricciuti, Biagio; Siringo, Marco; Marinelli, Daniele; Gelibter, Alain; Pecci, Federica; Berardi, Rossana; Cantini, Luca; Di Federico, Alessandro; Andrini, Elisa; Mosca, Mirta; Lamberti, Giuseppe; Brambilla, Marta; Mountzios, Giannis | |
| Anti-PD1 therapies induce an early expansion of Ki67+CD8+ T cells in metastatic non-oncogene addicted NSCLC patients | 2024 | Gelibter, Alain; Tuosto, Lucrezia; Asquino, Angela; Siringo, Marco; Sabatini, Arianna; Zizzari, ILARIA GRAZIA; Pace, Angelica; Scirocchi, Fabio; Valentino, Flavio; Bianchini, Serena; Caponnetto, Salvatore; Paoli, Donatella; Bellati, Filippo; Santini, Daniele; Nuti, Marianna; Rughetti, Aurelia; Napoletano, Chiara | |
| Blood Extracellular Vesicles beyond Circulating Tumour Cells: A Valuable Risk Stratification Biomarker in High-Risk Non-Muscle-Invasive Bladder Cancer Patients | 2024 | Magri, Valentina; Marino, Luca; DEL GIUDICE, Francesco; DE MEO, Michela; Siringo, Marco; DE BERARDINIS, Ettore; Gandini, Orietta; Santini, Daniele; Nicolazzo, Chiara; Gazzaniga, Paola | |
| CD137+ and regulatory T cells as independent prognostic factors of survival in advanced non-oncogene addicted NSCLC patients treated with immunotherapy as first-line | 2024 | Gelibter, Alain; Asquino, Angela; Strigari, Lidia; Zizzari, Ilaria; Tuosto, Lucrezia; Scirocchi, Fabio; Pace, Angelica; Siringo, Marco; Tramontano, Elisa; Bianchini, Serena; Bellati, Filippo; Botticelli, Andrea; Paoli, Donatella; Santini, Daniele; Nuti, Marianna; Rughetti, Aurelia; Napoletano, Chiara | |
| Circulating Cancer-Associated Macrophage-like Cells as a Blood-Based Biomarker of Response to Immune Checkpoint Inhibitors | 2024 | Magri, Valentina; DE RENZI, Gianluigi; Marino, Luca; DE MEO, Michela; Siringo, Marco; Gelibter, Alain; Gareri, Roberta; Cataldi, Chiara; Giannini, Giuseppe; Santini, Daniele; Nicolazzo, Chiara; Gazzaniga, Paola | |
| Circulating CD137+ T cell subsets and MDCSs as immune biomarkers for response to anti-PD1 immunotherapy in NSCLC patients | 2023 | Asquino, Angela; Tuosto, Lucrezia; Scirocchi, Fabio; Pace, Angelica; Zizzari, ILARIA GRAZIA; Siringo, Marco; Tramontano, Elisa; Gelibter, Alain; Cortesi, Enrico; Nuti, Marianna; Rughetti, Aurelia; Napoletano, Chiara | |
| Circulating CD137+T cells as an immune biomarker for response to anti-PD1 immunotherapy in NSCLC patients | 2023 | Asquino, Angela; Scirocchi, Fabio; Pace, Angelica; Zizzari, ILARIA GRAZIA; Siringo, Marco; Tramontano, Elisa; Cortesi, Enrico; Gelibter, Alain; Nuti, Marianna; Rughetti, Aurelia; Napoletano, Chiara | |
| Clinical utility of combined plasma and tissue NGS in patients with advanced, treatment-naïve, Non-small Cell Lung Cancer | 2023 | Bote de Cabo, H.; Siringo, M.; García-Lorenzo, E.; Castelo, A.; Conde, E.; Hernández, S.; López-Ríos Moreno, F.; Herrera, M.; Baena, J.; Ruano-Domínguez, Y.; Enguita, A. B.; Pérez, U.; Paz-Ares, L.; Zugazagoitia, J. | |
| Clinical Utility of Combined Plasma and Tissue NGS in Patients With Newly Diagnosed Advanced Non-Small Cell Lung Cancer | 2023 | Bote De Cabo, H.; Siringo, M.; García-Lorenzo, E.; Castelo, A.; Conde, E.; Hernández, S.; López-Ríos Moreno, F.; Paz-Ares, L.; Zugazagoitia, J. | |
| Clinical Utility of Combined Tissue and Plasma Next-Generation Sequencing in Patients with Advanced, Treatment-Naïve, Non-Small-Cell Lung Cancer | 2024 | Cabo, Helena Bote-de; Siringo, Marco; Conde, Esther; Hernández, Susana; López-Ríos, Fernando; Castelo-Loureiro, Alicia; García-Lorenzo, Esther; Baena, Javier; Herrera, Mercedes; Enguita, Ana Belén; Ruano, Yolanda; Zugazagoitia, Jon; Paz-Ares, Luis | |
| Co-Occurrence of ALK rearrangement and KRAS G12C mutation in NSCLC. Report of two cases | 2024 | Siringo, M; Larocca, F; Spagnuolo, A; Gentile, G; Anile, M; Diso, D; Santini, D; Gelibter, A | |
| Comparison between liquid biopsy and tissue NGS in two cohorts of advanced NSCLC | 2023 | Bote, Helena; Siringo, Marco; García-Lorenzo, Esther; Castelo, Alicia; Conde, Esther; Hernández, Susana; Herrera, Mercedes; Ruano-Domínguez, Yolanda; Baena, Javier; Enguita, Ana Belén; Lopez-Rios Moreno, Fernando; Zugazagoitia, Jon; Paz-Ares, Luis G. | |
| Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy | 2021 | Cortellini, A.; Di Maio, M.; Nigro, O.; Leonetti, A.; Cortinovis, D. L.; Aerts, J. G. J. V.; Guaitoli, G.; Barbieri, F.; Giusti, R.; Ferrara, M. G.; Bria, E.; D'Argento, E.; Grossi, F.; Rijavec, E.; Guida, A.; Berardi, R.; Torniai, M.; Sforza, V.; Genova, C.; Mazzoni, F.; Garassino, M. C.; De Toma, A.; Signorelli, D.; Gelibter, A.; Siringo, M.; Marchetti, P.; Macerelli, M.; Rastelli, F.; Chiari, R.; Rocco, D.; Della Gravara, L.; Inno, A.; Michele, D. T.; Grassadonia, A.; Di Marino, P.; Mansueto, G.; Zoratto, F.; Filetti, M.; Santini, D.; Citarella, F.; Russano, M.; Cantini, L.; Tuzi, A.; Bordi, P.; Minuti, G.; Landi, L.; Ricciardi, S.; Migliorino, M. R.; Passiglia, F.; Bironzo, P.; Metro, G.; Adamo, V.; Russo, A.; Spinelli, G. P.; Banna, G. L.; Friedlaender, A.; Addeo, A.; Cannita, K.; Ficorella, C.; Porzio, G.; Pinato, D. J. | |
| EP08.02-046 Activity of OsimeRTInib in NSCLC with Uncommon EGFR Mutations: Retrospective Observational Multicenter Study (ARTICUNO) | 2022 | Pizzutilo, E. G.; Agostara, A. G.; Oresti, S.; Signorelli, D.; Giannetta, L. G.; Stabile, S.; Lauricella, C.; Amatu, A.; Brambilla, M.; Lo Russo, G.; Proto, C.; Mazzeo, L.; Beninato, T.; Siringo, M.; Giusti, R.; Filetti, M.; Genova, C.; Barletta, G.; Russano, M.; Di Fazio, G. R.; Tosoni, E.; Metro, G.; Pilotto, S.; Carta, A.; Mazzoni, F.; Roca, E.; Gelibter, A. J.; Gori, S.; Berardi, R.; Cerea, G.; Sartore-Bianchi, A.; Siena, S. | |
| Evaluation of efficacy of ALK inhibitors according to body mass index in ALK rearranged NSCLC patients—A retrospective observational study | 2023 | Siringo, Marco; Gentile, Gabriella; Caponnetto, Salvatore; Sperduti, Isabella; Santini, Daniele; Cortesi, Enrico; Gelibter, ALAIN JONATHAN | |
| Future Perspectives in the Second Line Therapeutic Setting for Non-Oncogene Addicted Non-Small-Cell Lung Cancer | 2023 | Siringo, Marco; Baena, Javier; Bote de Cabo, Helena; Torres-Jiménez, Javier; Zurera, María; Zugazagoitia, Jon; Paz-Ares, Luis | |
| Immunological network signature of naïve non-oncogene-addicted non-small cell lung cancer patients treated with anti-PD1 therapy. A pilot study | 2025 | Sibilio, Pasquale; Zizzari, ILARIA GRAZIA; Gelibter, Alain; Siringo, Marco; Tuosto, Lucrezia; Pace, Angelica; Asquino, Angela; Valentino, Flavio; Sabatini, Arianna; Petti, Manuela; Bellati, Filippo; Santini, Daniele; Nuti, Marianna; Farina, Lorenzo; Rughetti, Aurelia; Napoletano, Chiara | |
| Non-small-cell lung cancer: how to manage ALK-, ROS1- and NTRK-rearranged disease | 2022 | Marinelli, Daniele; Siringo, Marco; Metro, Giulio; Ricciuti, Biagio; Gelibter, Alain J |